Patents Assigned to Laboratories Alcon S.A.
  • Patent number: 4897412
    Abstract: Antiglaucoma compounds having beta adrenoreceptor antagonist properties and alpha adrenoreceptor antagonist properties are described. The compounds comprise a beta blocker-derived moiety designed to provide beta antagonist properties and an imidazolidine moiety designed to provide alpha-antagonist properties. Methods of synthesizing the compounds are also described. The compounds are useful in the treatment of glaucoma due to their ability to lower elevated intraocular pressure.
    Type: Grant
    Filed: January 19, 1989
    Date of Patent: January 30, 1990
    Assignee: Laboratories Alcon S.A.
    Inventors: Gerard LeClerc, Didier Huber, Jacques Himber, Guy Andermann